Tag: New Product Approval

Zydus Novel CKD Anaemia Drug Receives Ch

Indian pharma major Zydus Lifesciences has received approval from China’s National Medical Products Administration (NMPA)

USFDA Approves Aurobindo Subsidiary’s

The USFDA has Approved the NDA for ADQUEY (Difamilast 1%) ointment for the treatment of

FDA Approves Insmed’s New Oral Lung Di

USFDA has approved Insmed’s Brinsupri (Brensocatib) for Bronchiectasis, a chronic drug disease. The medicinal product

New NSCLC Drug Approved by USFDA –

China’s rise in cutting-edge pharmaceutical innovation received a major fillip with the USFDA approval of

FDA Approves Sanofi’s New Hemophilia 

The U.S. Food and Drug Administration (FDA) has approved Sanofi’s Qfitlia (fitusiran) for the treatment

FDA Approves New Skin Cancer Drug

USFDA has approved Checkpoint Therapeutics Cosibelimab-ipdl (Unloxcyt) for treatment of skin cancer CSCC (metastatic cutaneous squamous

FDA Approves New Drug for Control of And

The USFDA has approved Neurocrine Biosciences’ new drug, Crenessity (Crinecerfont), for the treatment of classic

FDA approves Roche’s Inavolisib fo

USFDA has approved Inavolisib ((Itovebi) of Genentech in combination with palbociclib and fulvestrant, for the

FDA Approves New Molecular Entity Lazert

FDA has given approval for Janssen’s New Molecular Entity Lazertinib (Lazcluze). Approval is accorded for

FDA approves Gileads Liver Drug Livdelzi

Gilead announced FDAs approval of Livdelzi (Seladelpar) for treatment of PBC, a rare, chronic, autoimmune